These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3567252)

  • 21. Evidence for muscarinic receptors on rat colonic epithelial cells: binding of [3H]quinuclidinyl benzilate.
    Rimele TJ; O'Dorisio MS; Gaginella TS
    J Pharmacol Exp Ther; 1981 Aug; 218(2):426-34. PubMed ID: 7252842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biphasic regulation of detergent-solubilized muscarinic acetylcholine receptors from rat cerebral cortex by N-ethylmaleimide.
    Dennison RL; Wenger DA; Aronstam RS
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):465-8. PubMed ID: 3992023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kindled seizures selectively reduce a subpopulation of [3H]quinuclidinyl benzilate binding sites in rat dentate gyrus.
    Savage DD; McNamara JO
    J Pharmacol Exp Ther; 1982 Sep; 222(3):670-3. PubMed ID: 7108770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cholinergic role in the mechanism of lithium in mania.
    Tollefson GD; Senogles S
    Biol Psychiatry; 1983 Apr; 18(4):467-79. PubMed ID: 6860721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]quinuclidinyl benzilate binding in rats.
    Pelham RW; Munsat TL
    Brain Res; 1979 Aug; 171(3):473-80. PubMed ID: 476482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of [3H]quinuclidinyl benzilate to regions of rat pituitary and hypothalamus.
    Hoover DB; Hancock JC; Talley NS
    Brain Res Bull; 1981 Mar; 6(3):209-11. PubMed ID: 7225899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The differential loss of [3H]pirenzepine vs [3H] (-) quinuclidinylbenzilate binding to soluble rat brain muscarinic receptors indicates that pirenzepine binds to an allosteric state of the muscarinic receptor.
    Roeske WR; Venter JC
    Biochem Biophys Res Commun; 1984 Feb; 118(3):950-7. PubMed ID: 6546685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two radiolabeled quinuclidinyl benzilate ligands for the characterization of the human peripheral lung muscarinic receptor.
    Joad JP; Casale TB
    Life Sci; 1987 Sep; 41(13):1577-84. PubMed ID: 3626772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscarinic receptor binding in sheep anterior pituitary.
    Burt DR; Taylor RL
    Neuroendocrinology; 1980 Jun; 30(6):344-9. PubMed ID: 7383273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific [3H]quinuclidinyl benzilate binding activity in digitonin-solubilized preparations from bovine brain.
    Hurko O
    Arch Biochem Biophys; 1978 Oct; 190(2):434-45. PubMed ID: 718161
    [No Abstract]   [Full Text] [Related]  

  • 32. Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs.
    Nedoma J; Tucek S; Danilov AF; Shelkovnikov SA
    J Pharmacol Exp Ther; 1986 Jan; 236(1):219-23. PubMed ID: 3941394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical characterization of solubilized muscarinic acetylcholine receptors.
    Repke H; Matthies H
    Brain Res Bull; 1980; 5(6):703-9. PubMed ID: 7470941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of deoxyribonuclease I and neuraminidase treatments on the specific binding of 3H-prazosin and 3H-quinuclidinyl benzilate (3H-QNB) to alpha-adrenergic and muscarinic receptors in rat myocardial membranes.
    Nagatomo T; Tsuchihashi H; Imai S
    Jpn J Pharmacol; 1986 May; 41(1):135-8. PubMed ID: 3016391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ascorbate induced lipid peroxidation results in loss of receptor binding in tris, but not in phosphate, buffer. Implications for the involvement of metal ions.
    Abe K; Kogure K; Arai H; Nakano M
    Biochem Int; 1985 Sep; 11(3):341-8. PubMed ID: 3933512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo autoradiographic competition studies of isomers of [125I]IQNP against QNB demonstrating in vivo m2 muscarinic subtype selectivity for QNB.
    Zeeberg BR; Boulay SF; Sood VK; Rayeq MR; Danesh RA; McPherson DW; Knapp FF
    Recept Signal Transduct; 1997; 7(1):45-54. PubMed ID: 9285530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solubilization of the membrane-bound enzymes of the brush-border plasma membrane of Hymenolepis diminuta (Cestoda) using nonionic detergents.
    Pappas PW
    J Parasitol; 1982 Aug; 68(4):588-92. PubMed ID: 6288906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW; Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of [3H]quinuclidinyl benzilate to intestinal mucus. An artifact in identification of epithelial cell muscarinic receptors.
    Rimele TJ; Gaginella TS
    Biochem Pharmacol; 1982 Feb; 31(4):515-20. PubMed ID: 7066020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.